Revelation Biosciences (REVB) Shares Outstanding (2020 - 2026)
Revelation Biosciences (REVB) reported Shares Outstanding of 3.83 million for Q2 2026, compared with 200,668 a year earlier and up 19.4% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Shares Outstanding (2020 - 2026) Analysis & Trends
For FY2025, Revelation Biosciences posted Shares Outstanding of 620,785.
- Shares Outstanding has a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 14,292 in FY2024, 1,191 in FY2023 (-57.6%), 2,807 in FY2022 (-70.4%) and 9,477 in FY2021 (-58.4%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q1 2020.
- The high point for year-over-year Shares Outstanding in five years was Q3 2023 (growth of 929.1%); the low point was Q1 2023 (a decline of 84.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 3.21 million (Q1 2026), 620,785 (Q4 2025) and 661,183 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | 3.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.83 Mn |
| Mar 31, 2026 | 3.21 Mn |
| Dec 31, 2025 | 620,785.00 |
| Sep 30, 2025 | 661,183.00 |
| Jun 30, 2025 | 200,668.00 |
| Mar 31, 2025 | 80,942.00 |
| Dec 31, 2024 | 14,292.00 |
| Sep 30, 2024 | 13,958.00 |
| Jun 30, 2024 | 8,517.00 |
| Mar 31, 2024 | 5,676.00 |
| Dec 31, 2023 | 1,191.00 |
| Sep 30, 2023 | 32,798.00 |
| Jun 30, 2023 | 30,272.00 |
| Mar 31, 2023 | 11,514.00 |
| Dec 31, 2022 | 2,807.00 |
| Sep 30, 2022 | 3,187.00 |
| Jun 30, 2022 | 2,299.00 |
| Mar 31, 2022 | 73,968.00 |
| Dec 31, 2021 | 9,477.00 |
| Sep 30, 2021 | 9,477.00 |
API Access
Revelation Biosciences Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();